<SEC-DOCUMENT>0000902664-25-004989-index.html : 20251114
<SEC-HEADER>0000902664-25-004989.hdr.sgml : 20251114
<ACCEPTANCE-DATETIME>20251114160332
ACCESSION NUMBER:		0000902664-25-004989
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251114
DATE AS OF CHANGE:		20251114

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KalVista Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001348911
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				200915291
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88797
		FILM NUMBER:		251485671

	BUSINESS ADDRESS:	
		STREET 1:		200 CROSSING BOULEVARD
		CITY:			FRAMINGHAM
		STATE:			MA
		ZIP:			01702
		BUSINESS PHONE:		(857) 999-0075

	MAIL ADDRESS:	
		STREET 1:		200 CROSSING BOULEVARD
		CITY:			FRAMINGHAM
		STATE:			MA
		ZIP:			01702

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Carbylan Therapeutics, Inc.
		DATE OF NAME CHANGE:	20140916

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Carbylan Biosurgery, Inc
		DATE OF NAME CHANGE:	20130102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Carbylan Biosurgery Inc
		DATE OF NAME CHANGE:	20060105

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vestal Point Capital, LP
		CENTRAL INDEX KEY:			0001974915
		ORGANIZATION NAME:           	
		EIN:				922296021
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		632 BROADWAY
		STREET 2:		SUITE 602
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10012
		BUSINESS PHONE:		6469894000

	MAIL ADDRESS:	
		STREET 1:		632 BROADWAY
		STREET 2:		SUITE 602
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10012
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>